Dan Roden
Faculty Member
Last active: 3/24/2020

New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine.

Relling MV, Krauss RM, Roden DM, Klein TE, Fowler DM, Terada N, Lin L, Riel-Mehan M, Do TP, Kubo M, Yee SW, Johnson GT, Giacomini KM
Clin Pharmacol Ther. 2017 102 (6): 897-902

PMID: 28795399 · PMCID: PMC5706548 · DOI:10.1002/cpt.755

The goal of pharmacogenomics research is to discover genetic polymorphisms that underlie variation in drug response. Increasingly, pharmacogenomics research involves large numbers of patients and the application of new technologies and methodologies to enable discovery. The Pharmacogenomics Research Network (PGRN) has become a community-driven network of investigators spanning scientific and clinical disciplines. Here, we highlight the activities and types of resources that enable PGRN members to enhance and drive basic and translational research in pharmacogenomics.

© 2017 American Society for Clinical Pharmacology and Therapeutics.

MeSH Terms (5)

Biomedical Research Humans Pharmacogenetics Precision Medicine Translational Medical Research

Connections (1)

This publication is referenced by other Labnodes entities: